Concepedia

Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women

Jessica A. Kahn, Jiahong Xu, Bill G. Kapogiannis, Bret J. Rudy, René Gonin, Nancy Liu, Craig M. Wilson, Carol Worrell, Kathleen Squires

Clinical Infectious Diseases · 2013 · 111 citations · 33 references

DOIFull text

Open access

Abstract

In a sample of HIV-infected women who were HPV DNA and HPV seronegative, immune responses to HPV vaccination were generally robust and the vaccine was well tolerated.

References

33

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

New England Journal of Medicine · 2007 · 2K citations · Full text

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Suzanne M. Garland, Mauricio Hernández‐Ávila, Cosette M. Wheeler et al. · New England Journal of Medicine · 2007 · 1.9K citations

Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Markowitz Le · Medical Entomology and Zoology · 2007 · 1.6K citations

, , +14

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

, , +9

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen, David Jenkins, F. Xavier Bosch et al. · The Lancet · 2007 · 1.3K citations

, , +9